(VIANEWS) – Grupo Aeroportuario del Centro Norte S.A.B. de C.V. (OMAB), Esquire Financial Holdings (ESQ), STARWOOD PROPERTY TRUST (STWD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Grupo Aeroportuario del Centro Norte S.A.B. de C.V. (OMAB)
39.2% sales growth and 38.62% return on equity
Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., together with its subsidiaries, holds concessions to develop, operate, and maintain airports in Mexico. The company operates 13 international airports in Monterrey, Acapulco, Mazatlán, Zihuatanejo, Ciudad Juárez, Reynosa, Chihuahua, Culiacán, Durango, San Luis Potosí, Tampico, Torreón, and Zacatecas cities. It also operates the NH Collection Hotel in Terminal 2 of the Mexico City International Airport; and a hotel under the Hilton Garden Inn name at the Monterrey International Airport. In addition, the company provides aeronautical services, which include passenger, aircraft landing and parking, boarding and unloading, passenger walkway, and airport security services. Further, it offers complementary services that comprise leasing of space to airlines, cargo handling, baggage-screening, permanent and non-permanent ground transportation, and access rights services; non-aeronautical services, such as leasing of space at its airports to retailers, restaurants, and other commercial tenants, as well as maintaining of parking facilities and advertising; and diversification services, which consists of operation and lease of the industrial park and real estate services, as well as hotel and air cargo logistics services. Additionally, the company provides construction services. It has a strategic alliance with VYNMSA Desarrollo Inmobiliario, S.A. de C.V. to build and operate an industrial park at the Monterrey airport. The company was founded in 1998 and is headquartered in Mexico City, Mexico.
Earnings Per Share
As for profitability, Grupo Aeroportuario del Centro Norte S.A.B. de C.V. has a trailing twelve months EPS of $0.55.
PE Ratio
Grupo Aeroportuario del Centro Norte S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 134.87. Meaning, the purchaser of the share is investing $134.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.62%.
Yearly Top and Bottom Value
Grupo Aeroportuario del Centro Norte S.A.B. de C.V.’s stock is valued at $74.45 at 15:22 EST, below its 52-week high of $76.59 and way above its 52-week low of $46.53.
2. Esquire Financial Holdings (ESQ)
37.3% sales growth and 18.29% return on equity
Esquire Financial Holdings, Inc. operates as the bank holding company for Esquire Bank, National Association that provides commercial banking products and services to legal industry and small businesses, and commercial and retail customers in the United States. The company offers checking, savings, money market, and time deposits, as well as certificates of deposit. It also provides commercial loans, including short-term financing for inventory, receivables, the purchase of supplies, or other operating needs arising during the normal course of business, as well as loans to its qualified merchant customers; commercial lines of credit; consumer loans consisting of post-settlement consumer and structured settlement loans to plaintiffs and claimants, as well as loans to individuals for debt consolidation, medical expenses, living expenses, payment of outstanding bills, or other consumer needs; and real estate loans, such as multifamily, 1-4 family residential, commercial real estate, and construction loans, as well as merchant services. As of December 31, 2020, the company operated a full-service branch in Jericho, New York; and an administrative office in Boca Raton, Florida. Esquire Financial Holdings, Inc. was founded in 2006 and is headquartered in Jericho, New York.
Earnings Per Share
As for profitability, Esquire Financial Holdings has a trailing twelve months EPS of $1.86.
PE Ratio
Esquire Financial Holdings has a trailing twelve months price to earnings ratio of 24.14. Meaning, the purchaser of the share is investing $24.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.29%.
Volume
Today’s last reported volume for Esquire Financial Holdings is 3762 which is 84.19% below its average volume of 23796.
Revenue Growth
Year-on-year quarterly revenue growth grew by 71.2%, now sitting on 73.32M for the twelve trailing months.
Sales Growth
Esquire Financial Holdings’s sales growth is 36.3% for the current quarter and 37.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 18.1% and 45.5%, respectively.
3. STARWOOD PROPERTY TRUST (STWD)
36.8% sales growth and 15.22% return on equity
Starwood Property Trust, Inc. operates as a real estate investment trust (REIT) in the United States and Europe. It operates through four segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing segments. The Commercial and Residential Lending segment originates, acquires, finances, and manages commercial and residential first mortgages, non-agency residential mortgages, subordinated mortgages, mezzanine loans, preferred equity, commercial mortgage-backed securities (CMBS), residential mortgage-backed securities, and other real estate and real estate-related debt investments. The Infrastructure lending segment originates, acquires, finances, and manages infrastructure debt investments. The Property segment engages primarily in the acquiring and managing equity interests in stabilized commercial real estate properties, including multi-family properties. The Investing and Servicing segment manages and works out problem assets; acquires and manages unrated, investment grade, and non-investment grade rated CMBS, including subordinated interests of securitization and re-securitization transactions; originates conduit loans for the primary purpose of selling these loans into securitization transactions; and acquires commercial real estate assets, including properties acquired from CMBS trusts. The company qualifies as a REIT for federal income tax purposes and would not be subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its stockholders. Starwood Property Trust, Inc. was founded in 2009 and is headquartered in Greenwich, Connecticut.
Earnings Per Share
As for profitability, STARWOOD PROPERTY TRUST has a trailing twelve months EPS of $1.16.
PE Ratio
STARWOOD PROPERTY TRUST has a trailing twelve months price to earnings ratio of 18.48. Meaning, the purchaser of the share is investing $18.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.22%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 14.8%, now sitting on 675.88M for the twelve trailing months.
Yearly Top and Bottom Value
STARWOOD PROPERTY TRUST’s stock is valued at $21.40 at 15:22 EST, way under its 52-week high of $25.06 and way higher than its 52-week low of $17.69.
Sales Growth
STARWOOD PROPERTY TRUST’s sales growth is 18.3% for the current quarter and 36.8% for the next.
4. DexCom (DXCM)
18.9% sales growth and 9.19% return on equity
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $5.2.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 22.74. Meaning, the purchaser of the share is investing $22.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.19%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 112.5% and 35.3%, respectively.
Moving Average
DexCom’s value is higher than its 50-day moving average of $111.78 and way above its 200-day moving average of $94.81.
Yearly Top and Bottom Value
DexCom’s stock is valued at $118.36 at 15:22 EST, way under its 52-week high of $134.76 and way higher than its 52-week low of $66.89.
5. Option Care Health (OPCH)
9% sales growth and 14.66% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $0.99.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 28.87. Meaning, the purchaser of the share is investing $28.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.66%.
Volume
Today’s last reported volume for Option Care Health is 232011 which is 79.23% below its average volume of 1117330.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $28.58 at 15:22 EST, way under its 52-week high of $35.87 and way above its 52-week low of $21.52.
Sales Growth
Option Care Health’s sales growth is 10.4% for the ongoing quarter and 9% for the next.
6. Medallion Financial Corp. (MFIN)
6.9% sales growth and 18.42% return on equity
Medallion Financial Corp., together with its subsidiaries, operates as a finance company in the United States. It originates, acquires, and services loans that finance taxi medallions and various types of commercial businesses. The company offers consumer loans for the purchase of recreational vehicles, boats, motorcycles, and trailers, as well as to finance home improvements; commercial loans for the purchase of equipment and related assets necessary to open a new business, or purchase or improvement of an existing business; and medallion loans. It also provides debt, mezzanine, and equity investment capital to companies in various industries. In addition, the company raises deposits and conducts other banking activities. Medallion Financial Corp. was founded in 1995 and is headquartered in New York City, New York.
Earnings Per Share
As for profitability, Medallion Financial Corp. has a trailing twelve months EPS of $-0.52.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.42%.
Sales Growth
Medallion Financial Corp.’s sales growth is 11.4% for the ongoing quarter and 6.9% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 64.1% and a negative 28.2%, respectively.
7. Universal Health Services (UHS)
6.9% sales growth and 11.73% return on equity
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 25, 2021, it owned and/or operated 360 inpatient facilities, and 39 outpatient and other facilities located in 38 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Earnings Per Share
As for profitability, Universal Health Services has a trailing twelve months EPS of $11.79.
PE Ratio
Universal Health Services has a trailing twelve months price to earnings ratio of 12.66. Meaning, the purchaser of the share is investing $12.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.73%.
Yearly Top and Bottom Value
Universal Health Services’s stock is valued at $149.29 at 15:22 EST, under its 52-week high of $158.28 and way above its 52-week low of $82.50.
8. MaxLinear (MXL)
6% sales growth and 22.76% return on equity
MaxLinear, Inc. provides radio-frequency (RF), high-performance analog, and mixed-signal communications systems-on-chip solutions (SoCs) for the connected home, wired and wireless infrastructure, and industrial and multi-market applications worldwide. The company offers various semiconductor products, such as RF receivers and RF receiver SoCs, wireless infrastructure backhaul RF receivers and modem SoCs, laser modulator drivers, transimpedance amplifiers, clock and data recovery circuits, interface solutions, power management products, and data encryption and compression products. Its products are used in a range of electronic devices, including cable DOCSIS broadband modems and gateways, wireline connectivity devices for in-home networking applications, RF transceivers and modems, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company sells its products to electronics distributors, module makers, original equipment manufacturers, and original design manufacturers through direct sales force, third party sales representatives, and a network of distributors. MaxLinear, Inc. was founded in 2003 and is headquartered in Carlsbad, California.
Earnings Per Share
As for profitability, MaxLinear has a trailing twelve months EPS of $1.59.
PE Ratio
MaxLinear has a trailing twelve months price to earnings ratio of 27.19. Meaning, the purchaser of the share is investing $27.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.76%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.4%, now sitting on 1.08B for the twelve trailing months.
